DSM is delighted to be showcasing at CPHI Worldwide 2022. From 1 – 3 November we invite visitors from across the industry to meet us at booth 120B120 to discover how we’re:
We’re uniquely powered to deliver more than active pharmaceutical ingredients. Uncover how we’re co-creating next generation, patient-focused solutions with purpose.
Discover co-innovation opportunities to mitigate nitrosamine risk with confidence. Explore our FDA-recommended inhibition strategy.
The possibilities are endless in the cannabinoid market. Learn how we’re partnering with customers in early drug development to realize the full potential of cannabinoid-based pharmaceuticals.
Explore our science-backed portfolio of sustained release delivery solutions and how they’re enabling advanced and sustainable innovation in the biomedical space.
Find out how we’re helping customers recognize the game-changing potential of medical nutrition in patient care. Plus, learn how our end-to-end capabilities are helping pharmaceutical manufacturers co-create drug products fit for purpose.
Committed to supporting patient health, but never considered nutrition? Discover how combining drug therapies with medical nutrition solutions is supporting better patient outcomes, recovery and quality of life, particularly for patients with cancer.
At DSM, we know purpose backed by the right expertise can help overcome even the most complex challenges. With more than 70 years of experience in in producing and securing the supply of high-quality APIs, and a passion for innovation and science, we’re your ideal partner for developing next generation therapeutics designed to support the health of patients worldwide.